FUTURESCOPE CONSULTING LTD
Company number 14705236 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
FUTURESCOPE CONSULTING LTD - Analysis Report
Company Number: 14705236
Analysis Date: 2025-07-29 18:03 UTC
Financial Health Assessment of FUTURESCOPE CONSULTING LTD
Assessment Date: Financial year ended 31 March 2024
1. Financial Health Score: B (Good)
Explanation: The company displays solid initial financial footing with positive net current assets and net equity. As a start-up private limited company incorporated less than two years ago, it shows healthy liquidity and no overdue filings. However, limited operational history and reliance on director loans suggest cautious optimism.
2. Key Vital Signs (Core Financial Metrics)
| Metric | Value (£) | Interpretation |
|---|---|---|
| Current Assets | 91,235 | Adequate short-term resources mainly cash and debtors |
| Cash and Bank Balance | 77,735 | Strong cash position indicating healthy cash flow |
| Debtors | 13,500 | Moderate receivables, manageable for a new consultancy |
| Current Liabilities | 37,845 | Includes VAT, taxes, and director loans - payables due soon |
| Net Current Assets | 53,390 | Positive working capital signals ability to cover short-term debts |
| Net Assets (Equity) | 53,390 | Entirely shareholder-funded; no long-term liabilities |
| Shareholder Funds | 53,390 | Reflects accumulated profits or initial capital injection |
| Employees | 1 | Very small workforce consistent with micro/small company |
Additional Observations:
- The company qualifies as a micro-entity under UK accounting standards, with exemption from audit.
- Director loan (£2,890) is relatively small but indicates some external financing from management.
- No profit and loss statement filed, so profitability status is unclear.
3. Diagnosis: What the Numbers Reveal About Business Health
Healthy Cash Flow ("Strong Pulse"): With £77,735 in cash against modest short-term liabilities, the company enjoys a strong liquidity position. This is critical for a young consultancy firm to meet immediate expenses and invest in growth.
Positive Working Capital ("Good Circulatory Health"): Net current assets of £53,390 demonstrate the company can comfortably cover its debts due within one year. This reduces risk of liquidity crises and supports operational stability.
Equity-Funded Start-Up ("Stable Skeleton"): The net assets equal shareholders’ funds, indicating the company currently relies on equity injections rather than external borrowing. This is typical and healthy for a start-up phase.
Limited Operational History ("Early Development Stage"): Incorporated in March 2023, the company has only completed its first financial year. The absence of detailed profit and loss data limits insight into profitability and margin health.
Director’s Financial Support ("Management’s Lifeline"): The presence of a director loan indicates management’s commitment to supporting cash flow but is a small component of liabilities.
No Audit Required ("Light Regulatory Burden"): Filing under small company exemptions reduces compliance cost and complexity, appropriate for the company’s scale.
4. Recommendations: Specific Actions to Improve Financial Wellness
Establish Profitability Tracking and Reporting: Begin preparing and submitting profit and loss accounts to monitor revenue generation, cost control, and profitability trends. This will provide better insight into operational health beyond balance sheet strength.
Monitor Debtor Collection ("Watch for Early Signs of Blocked Arteries"): Implement robust credit control to ensure receivables (£13,500) are collected timely to maintain cash flow.
Plan for Growth Investment: With strong cash reserves, consider strategic investments in marketing, technology, or hiring to build capacity and scale operations while maintaining liquidity buffer.
Limit Reliance on Director Loans: Formalise director loans and aim to reduce reliance by generating operational cash or seeking external funding if needed.
Maintain Compliance Vigilance ("Regular Health Checks"): Continue timely filing of accounts and confirmation statements to avoid penalties and maintain good standing.
Prepare for Future Audit Requirements: As the company grows beyond micro or small thresholds, plan for audit readiness and enhanced financial controls.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.